The Myc/Max/Mad network and the transcriptional control of cell behavior.

The Myc/Max/Mad network comprises a group of transcription factors whose distinct interactions result in gene-specific transcriptional activation or repression. A great deal of research indicates that the functions of the network play roles in cell proliferation, differentiation, and death. In this review we focus on the Myc and Mad protein families and attempt to relate their biological functions to their transcriptional activities and gene targets. Both Myc and Mad, as well as the more recently described Mnt and Mga proteins, form heterodimers with Max, permitting binding to specific DNA sequences. These DNA-bound heterodimers recruit coactivator or corepressor complexes that generate alterations in chromatin structure, which in turn modulate transcription. Initial identification of target genes suggests that the network regulates genes involved in the cell cycle, growth, life span, and morphology. Because Myc and Mad proteins are expressed in response to diverse signaling pathways, the network can be viewed as a functional module which acts to convert environmental signals into specific gene-regulatory programs.

[1]  P. Leder,et al.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor , 1983, Cell.

[2]  M. Cole,et al.  The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals , 2000, Molecular and Cellular Biology.

[3]  O. Volpert,et al.  An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[4]  G. Prendergast,et al.  c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. , 1994, The EMBO journal.

[5]  S. Goff,et al.  Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. , 1993, Science.

[6]  G. Prendergast,et al.  Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. , 1991, Science.

[7]  Ken Chen,et al.  Gene-target recognition among members of the Myc superfamily and implications for oncogenesis , 2000, Nature Genetics.

[8]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[9]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Evan,et al.  The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.

[11]  N. Jenkins,et al.  Mga, a dual‐specificity transcription factor that interacts with Max and contains a T‐domain DNA‐binding motif , 1999, The EMBO journal.

[12]  R. Eisenman,et al.  Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 , 1995, Cell.

[13]  A T Bankier,et al.  Characterization of a transcription factor involved in mother cell specific transcription of the yeast HO gene. , 1988, The EMBO journal.

[14]  G. D. Spotts,et al.  Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells , 1990, Molecular and cellular biology.

[15]  S. Werner,et al.  Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. , 1996, British Journal of Cancer.

[16]  J. Rossant,et al.  Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. , 1993, Development.

[17]  M. Barone,et al.  Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src , 1995, Nature.

[18]  L. Chin,et al.  Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression , 1997, nature.

[19]  R. Eisenman,et al.  Sin Meets NuRD and Other Tails of Repression , 1999, Cell.

[20]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[21]  R. Eisenman,et al.  c-Myc enhances protein synthesis and cell size during B lymphocyte development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Leder,et al.  Functional role for c-myc in mitogenic response to platelet-derived growth factor , 1984, Nature.

[23]  M. Eilers,et al.  Control of cell proliferation by Myc. , 1998, Trends in cell biology.

[24]  J. Nevins,et al.  Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals , 1997, Molecular and cellular biology.

[25]  D. Wechsler,et al.  MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. , 1997, Cancer research.

[26]  C. Cultraro,et al.  Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation , 1997, Molecular and cellular biology.

[27]  G. Prendergast,et al.  Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.

[28]  Q. Zhan,et al.  Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents , 1998, Oncogene.

[29]  J. Karn,et al.  Regulation of cell cycle duration by c-myc levels. , 1989, Oncogene.

[30]  G. Evan,et al.  c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.

[31]  R. Eisenman,et al.  A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.

[32]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[33]  F. Alt,et al.  Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes. , 1992, Genes & development.

[34]  M. Eilers,et al.  Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases , 1997, Oncogene.

[35]  R. Brent,et al.  Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. , 1994, Oncogene.

[36]  A. J. Walhout,et al.  c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene. , 1997, Nucleic acids research.

[37]  R. Eisenman,et al.  Sequential expression of the MAD family of transcriptional repressors during differentiation and development , 1998, Oncogene.

[38]  B. Amati,et al.  Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. , 1994, Current opinion in genetics & development.

[39]  C. Dang,et al.  Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene? , 1995, Molecular and cellular biology.

[40]  M. Roussel,et al.  Inhibition of cell proliferation by the Mad1 transcriptional repressor , 1996, Molecular and cellular biology.

[41]  C. Dang,et al.  Max: functional domains and interaction with c-Myc. , 1992, Genes & development.

[42]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[43]  E. Prochownik,et al.  Commonly occurring loss and mutation of the MXI1 gene in prostate cancer , 1998, Genes, chromosomes & cancer.

[44]  V. Sorrentino,et al.  Potentiation of growth factor activity by exogenous c-myc expression. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[46]  M. Linial,et al.  Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor Gene* , 1996, The Journal of Biological Chemistry.

[47]  D. Ledbetter,et al.  Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non‐canonical E box and acts as a transcriptional repressor , 1997, The EMBO journal.

[48]  A Ciechanover,et al.  Degradation of nuclear oncoproteins by the ubiquitin system in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. DePinho,et al.  Repression by the Mad(Mxi1)‐Sin3 complex , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[50]  E. Ziff,et al.  Mxi1 Is a Repressor of the c-myc Promoter and Reverses Activation by USF* , 1999, The Journal of Biological Chemistry.

[51]  R. Tjian,et al.  Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II , 1995, Cell.

[52]  S. Mai,et al.  c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines. , 1996, Oncogene.

[53]  R. Eisenman,et al.  Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein. , 1994, Molecular biology of the cell.

[54]  G. Falcone,et al.  Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells , 1989, Cell.

[55]  C. Dang,et al.  Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Gillespie,et al.  The leucine zipper domain of avian cMyc is required for transformation and autoregulation. , 1990, Oncogene.

[57]  V. D’Agati,et al.  Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). , 1996, Oncogene.

[58]  A. Manning,et al.  Multiple signals converging on NF-κB , 1999 .

[59]  R. Eisenman,et al.  Myc‐Max heterodimers activate a DEAD box gene and interact with multiple E box‐related sites in vivo. , 1996, The EMBO journal.

[60]  D. Beach,et al.  Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.

[61]  G. Hannon,et al.  Myc activates telomerase. , 1998, Genes & development.

[62]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[63]  R. Eisenman,et al.  Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. , 1997, Genes & development.

[64]  M. DePamphilis,et al.  Is c-myc protein directly involved in DNA replication? , 1988, Science.

[65]  R. Davis,et al.  Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[66]  K. Isselbacher,et al.  Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  John R. Yates,et al.  Tra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes* , 1998, The Journal of Biological Chemistry.

[68]  H. Varmus,et al.  Definition of regions in human c-myc that are involved in transformation and nuclear localization , 1987, Molecular and cellular biology.

[69]  A. Joyner,et al.  A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. , 1992, Genes & development.

[70]  D. Gillespie,et al.  Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. , 1993, Oncogene.

[71]  R. Eeles,et al.  No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group. , 1997, British Journal of Cancer.

[72]  K. Arai,et al.  Signal transduction by the high‐affinity GM‐CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. , 1993, The EMBO journal.

[73]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[74]  G. Inghirami,et al.  Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. , 1990, Science.

[75]  M. Kastan,et al.  Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[76]  K Kornfeld,et al.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.

[77]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[78]  M. Cole,et al.  max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. , 1992, Oncogene.

[79]  P. Farnham,et al.  Identification of target genes of oncogenic transcription factors. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[80]  M. Polymenis,et al.  An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc , 1996, Molecular and cellular biology.

[81]  F M Watt,et al.  c-Myc promotes differentiation of human epidermal stem cells. , 1997, Genes & development.

[82]  L. Chin,et al.  Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc , 1999, Oncogene.

[83]  D. Green,et al.  Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.

[84]  M. Sporn,et al.  Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor , 1986, Molecular and cellular biology.

[85]  T. Lee,et al.  Myc represses transcription of the growth arrest gene gas1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[86]  T. McDonnell,et al.  Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.

[87]  G. Evan,et al.  Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.

[88]  M. Birrer,et al.  A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation , 1989, Molecular and cellular biology.

[89]  J. L. Quesne,et al.  C-Myc 5′ untranslated region contains an internal ribosome entry segment , 1998, Oncogene.

[90]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[91]  B. Emerson,et al.  Transcription of chromatin: these are complex times. , 1998, Current opinion in genetics & development.

[92]  D. Hanahan,et al.  Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. , 1995, Oncogene.

[93]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[94]  F. Watt,et al.  Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes. , 1995, Oncogene.

[95]  Javier León,et al.  c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells , 2000, Oncogene.

[96]  D. Prober,et al.  Drosophila myc Regulates Cellular Growth during Development , 1999, Cell.

[97]  J. Shay,et al.  Role of telomerase in cellular proliferation and cancer , 1999, Journal of cellular physiology.

[98]  A. Sewing,et al.  Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1 , 1999, The EMBO journal.

[99]  W. Schulz,et al.  Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. , 1989, Science.

[100]  M. Groudine,et al.  Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.

[101]  L. Desbarats,et al.  Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. , 1996, Genes & development.

[102]  Joseph R. Nevins,et al.  Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F , 1997, Nature.

[103]  C. Dang,et al.  Definition of the activities and properties of c-myc required to inhibit cell differentiation. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[104]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[105]  S. Mai,et al.  Myc-induced cyclin D2 genomic instability in murine B cell neoplasms. , 1999, Current topics in microbiology and immunology.

[106]  T. Taniguchi,et al.  IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: Demonstration of a novel role for c-myc , 1992, Cell.

[107]  S. Ishii,et al.  Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. , 1999, Genes & development.

[108]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[109]  B. Safer,et al.  Formation of α-Pal/Max Heterodimers Synergistically Activates the eIF2-α Promoter* , 1998, The Journal of Biological Chemistry.

[110]  A. Berns,et al.  Retroviral insertional mutagenesis as a strategy to identify cancer genes. , 1996, Biochimica et biophysica acta.

[111]  J. Cleveland,et al.  Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.

[112]  N. Hay,et al.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.

[113]  P. Brown,et al.  Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[114]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[115]  Hisato Kondoh,et al.  Transition of localization of the N-Myc protein from nucleus to cytoplasm in differentiating neurons , 1993, Neuron.

[116]  W. Schulz,et al.  A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis , 1991, Mechanisms of Development.

[117]  S. Schreiber,et al.  Three proteins define a class of human histone deacetylases related to yeast Hda1p. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[118]  Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc , 1998, Oncogene.

[119]  P. Leder,et al.  An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. , 1992, Genes & development.

[120]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[121]  D. Brough,et al.  An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation , 1995, Molecular and cellular biology.

[122]  K. Struhl,et al.  Repression by Ume6 Involves Recruitment of a Complex Containing Sin3 Corepressor and Rpd3 Histone Deacetylase to Target Promoters , 1997, Cell.

[123]  E. Prochownik,et al.  The leucine zipper of c-Myc is required for full inhibition of erythroleukemia differentiation , 1990, Molecular and cellular biology.

[124]  P. Neiman,et al.  The effect of alterations in myc gene expression on B cell development in the bursa of fabricius , 1987, Cell.

[125]  R. DePinho,et al.  Erratum: Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells (Nature Medicine (1995) 1 (638-643)) , 1995 .

[126]  S. Cory,et al.  Transgenic mice and oncogenesis. , 1988, Annual review of immunology.

[127]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[128]  Stuart L Schreiber,et al.  Histone Deacetylase Activity Is Required for Full Transcriptional Repression by mSin3A , 1997, Cell.

[129]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[130]  J. Nevins,et al.  erratum: Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F , 1997, Nature.

[131]  W. Ansorge,et al.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 , 1999, The EMBO journal.

[132]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[133]  F. Alt,et al.  myc family oncogenes in the development of normal and neoplastic cells. , 1991, Advances in cancer research.

[134]  L. Chin,et al.  Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse , 1999, Cell.

[135]  Arthur R. Brothman,et al.  Mutation of the MXI1 gene in prostate cancer , 1995, Nature Genetics.

[136]  H. Weintraub,et al.  Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. , 1992, Science.

[137]  D. Ayer,et al.  Mlx, a Novel Max-like BHLHZip Protein That Interacts with the Max Network of Transcription Factors* , 1999, The Journal of Biological Chemistry.

[138]  R. DePinho,et al.  Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[139]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[140]  S. Mai,et al.  The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability. , 1999, Gene.

[141]  G. Evan,et al.  Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. , 1999, Molecular cell.

[142]  L. Chin,et al.  Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. , 1996, Oncogene.

[143]  R. DePinho,et al.  Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth , 1998, Nature.

[144]  A. Perkins,et al.  Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. , 1992, Genes & development.

[145]  M. Cole,et al.  The Essential Cofactor TRRAP Recruits the Histone Acetyltransferase hGCN5 to c-Myc , 2000, Molecular and Cellular Biology.

[146]  R. Eisenman,et al.  Analysis of Myc/Max/Mad network members in adipogenesis: Inhibition of the proliferative burst and differentiation by ectopically expressed Mad1 , 2000, Journal of cellular physiology.

[147]  M. Cole,et al.  Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment , 1986, Nature.

[148]  J. Dunlap Molecular Bases for Circadian Clocks , 1999, Cell.

[149]  W. Gu,et al.  Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[150]  U. Pettersson,et al.  Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[151]  C. Seelos,et al.  Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. , 1995, Oncogene.

[152]  H. Weintraub,et al.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation , 1990, Cell.

[153]  G. Evan,et al.  Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.

[154]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[155]  J. Cleveland,et al.  c-Myc and apoptosis. , 1995, Biochimica et biophysica acta.

[156]  R. E. Esposito,et al.  RPD1 (SIN3/UME4) is required for maximal activation and repression of diverse yeast genes , 1991, Molecular and cellular biology.

[157]  R. DePinho,et al.  Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[158]  M. Roussel,et al.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. , 1999, Genes & development.

[159]  C. Dang,et al.  Binding and suppression of the Myc transcriptional activation domain by p107. , 1994, Science.

[160]  John M. Sedivy,et al.  c-Myc Regulates Cyclin D-Cdk4 and -Cdk6 Activity but Affects Cell Cycle Progression at Multiple Independent Points , 1999, Molecular and Cellular Biology.

[161]  C. Dang,et al.  c-Myc Overexpression Uncouples DNA Replication from Mitosis , 1999, Molecular and Cellular Biology.

[162]  Kou-Juey Wu,et al.  Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. , 1999, Science.

[163]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[164]  R. Klebe,et al.  Overview of matrix metalloproteinase expression in cultured human cells. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[165]  R. Davis,et al.  Cell cycle regulation of the c-Myc transcriptional activation domain , 1993, Molecular and cellular biology.

[166]  R. Versteeg,et al.  c‐myc down‐regulates class I HLA expression in human melanomas. , 1988, The EMBO journal.

[167]  M. Vidal,et al.  RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae , 1991, Molecular and cellular biology.

[168]  R. Eisenman,et al.  Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells , 1984, Molecular and cellular biology.

[169]  A. Chartier,et al.  Year : 1998 A Drosophila RNA helicase gene , pitchoune , is required for cell growth and proliferation and is a potential target of d-Myc , 2006 .

[170]  J. Sedivy Can ends justify the means?: telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[171]  L. Penn,et al.  Negative autoregulation of c‐myc transcription. , 1990, The EMBO journal.

[172]  N. Copeland,et al.  Mad3 and Mad4: novel Max‐interacting transcriptional repressors that suppress c‐myc dependent transformation and are expressed during neural and epidermal differentiation. , 1995, The EMBO journal.

[173]  H. Kondoh,et al.  Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. , 1991, The New biologist.

[174]  I. Magrath The pathogenesis of Burkitt's lymphoma. , 1990, Advances in cancer research.

[175]  U. Weidle,et al.  Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.

[176]  M. V. Heiden,et al.  Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[177]  Emmett V Schmidt,et al.  The role of c-myc in cellular growth control , 1999, Oncogene.

[178]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[179]  T. Ceska,et al.  The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control. , 1997, Structure.

[180]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[181]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[182]  Amanda G Paulovich,et al.  When Checkpoints Fail , 1997, Cell.

[183]  E. Gabrielson,et al.  c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. , 2000, Cancer research.

[184]  G. Carmichael,et al.  An alternative pathway for gene regulation by Myc , 1997, The EMBO journal.

[185]  M. Cole The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.

[186]  R. Eisenman,et al.  Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation , 1998, The EMBO journal.

[187]  F. Alt,et al.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. , 2000, Genes & development.

[188]  C. Dang,et al.  A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[189]  H. Ariga,et al.  Possible function of the c‐myc product: promotion of cellular DNA replication. , 1987, The EMBO journal.

[190]  S. Cory Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. , 1986, Advances in cancer research.

[191]  S Gaubatz,et al.  Transcriptional activation by Myc is under negative control by the transcription factor AP‐2. , 1995, The EMBO journal.

[192]  G. Gaidano,et al.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[193]  B. Amati,et al.  Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. , 1993, Nucleic acids research.

[194]  S. Salghetti,et al.  Destruction of Myc by ubiquitin‐mediated proteolysis: cancer‐associated and transforming mutations stabilize Myc , 1999, The EMBO journal.

[195]  M. Kasten,et al.  SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein , 1996, Molecular and cellular biology.

[196]  J F Barrett,et al.  Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[197]  K. Alitalo,et al.  Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro , 1995, The Journal of cell biology.

[198]  G. Evan,et al.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. , 1999, Genes & development.

[199]  J. Rossant,et al.  Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles , 1998, Current Biology.

[200]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[201]  R. Eisenman,et al.  Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[202]  M. Shen,et al.  Molecular genetics of prostate cancer. , 2000, Genes & development.

[203]  R. DePinho,et al.  Expression and activity of L-Myc in normal mouse development , 1996, Molecular and cellular biology.

[204]  W. Atchley,et al.  Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[205]  K. Alitalo,et al.  Repression of cyclin D1: a novel function of MYC. , 1994, Molecular and cellular biology.

[206]  T. P. Neufeld,et al.  Coordination of Growth and Cell Division in the Drosophila Wing , 1998, Cell.

[207]  R. Eisenman,et al.  Myc and Max Homologs in Drosophila , 1996, Science.

[208]  Bruno Amati,et al.  Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.

[209]  S. Coughlin,et al.  c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF , 1985, Cell.

[210]  A. Ferré-D’Amaré,et al.  Structure and function of the b/HLH/Z domain of USF , 1994 .

[211]  C. Busch,et al.  myc Boxes, Which Are Conserved in myc Family Proteins, Are Signals for Protein Degradation via the Proteasome , 1998, Molecular and Cellular Biology.

[212]  James M. Roberts,et al.  Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.

[213]  P. Farnham,et al.  Coexamination of Site-Specific Transcription Factor Binding and Promoter Activity in Living Cells , 1999, Molecular and Cellular Biology.

[214]  S. Freytag Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1 , 1988, Molecular and cellular biology.

[215]  T. Halazonetis,et al.  Determination of the c-MYC DNA-binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[216]  R. Eisenman,et al.  Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. , 1999, Biochimica et biophysica acta.

[217]  M. Pagano,et al.  Identification of a Myc‐dependent step during the formation of active G1 cyclin‐cdk complexes. , 1995, The EMBO journal.

[218]  R. DePinho,et al.  Essential role for Max in early embryonic growth and development. , 2000, Genes & development.

[219]  R. Eisenman,et al.  Myc target genes. , 1997, Trends in biochemical sciences.

[220]  M. Dickens,et al.  c-Myc Protein Synthesis Is Initiated from the Internal Ribosome Entry Segment during Apoptosis , 2000, Molecular and Cellular Biology.

[221]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[222]  G. Evan,et al.  Traps to catch unwary oncogenes. , 1998, Trends in genetics : TIG.

[223]  Wen‐Ming Yang,et al.  Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression , 1997, Cell.

[224]  R. Eisenman,et al.  Mad proteins contain a dominant transcription repression domain , 1996, Molecular and cellular biology.

[225]  R. Eisenman,et al.  Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[226]  D. Anderson,et al.  Immortalization and controlled in vitro differentiation of murine multipotent neural crest stem cells. , 1997, Journal of neurobiology.

[227]  L. M. Facchini,et al.  The molecular role of Myc in growth and transformation: recent discoveries lead to new insights , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[228]  A. Bradley,et al.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. , 1993, Genes & development.

[229]  G. Evan,et al.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max , 1992, Nature.

[230]  D. Gillespie,et al.  Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo. , 1993, The EMBO journal.

[231]  Mikhail Chernov,et al.  Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .

[232]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[233]  T. P. Neufeld,et al.  Connections between growth and the cell cycle. , 1998, Current opinion in cell biology.

[234]  K. Georgopoulos,et al.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes , 1999, The EMBO journal.

[235]  M. Cole,et al.  The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation , 1999, Oncogene.

[236]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[237]  C. Dang,et al.  Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells. , 1998, Cancer research.

[238]  A. Ciechanover,et al.  Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[239]  R. Stein,et al.  Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[240]  Wen‐Ming Yang,et al.  Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[241]  R. Eisenman,et al.  The Mad protein family links transcriptional repression to cell differentiation. , 1998, Cold Spring Harbor symposia on quantitative biology.

[242]  M. Grunstein Histone acetylation in chromatin structure and transcription , 1997, Nature.

[243]  S. Lowe,et al.  INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. , 1999, Genes & development.

[244]  M. West,et al.  Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway , 1998, Oncogene.

[245]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[246]  P. Farnham,et al.  c-Myc target gene specificity is determined by a post-DNAbinding mechanism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[247]  Jun Liu,et al.  A 13-Amino Acid Amphipathic α-Helix Is Required for the Functional Interaction between the Transcriptional Repressor Mad1 and mSin3A* , 1999, The Journal of Biological Chemistry.

[248]  J. Sedivy,et al.  Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. , 1998, Genes & development.

[249]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[250]  J. Bishop,et al.  Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. , 1989, Genes & development.

[251]  R. Roeder,et al.  Direct role for Myc in transcription initiation mediated by interactions with TFII-I , 1993, Nature.

[252]  J. Sedivy,et al.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[253]  P. Leder,et al.  Translocations among antibody genes in human cancer. , 1983, Science.

[254]  I. Magrath,et al.  Point mutations in the c–Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas , 1993, Nature Genetics.

[255]  T. Suuronen,et al.  Expression of transcriptional repressor protein mSin3A but not mSin3B is induced during neuronal apoptosis. , 1998, Biochemical and biophysical research communications.

[256]  R. Eisenman,et al.  c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock , 1988, Molecular and cellular biology.

[257]  S. Shurtleff,et al.  Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling , 1991, Nature.

[258]  E. Kremmer,et al.  Identification and Characterization of Specific DNA-binding Complexes Containing Members of the Myc/Max/Mad Network of Transcriptional Regulators* , 1998, The Journal of Biological Chemistry.

[259]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[260]  R Ohba,et al.  Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. , 1997, Genes & development.

[261]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[262]  M. Helmer-Citterich,et al.  Design and properties of a Myc derivative that efficiently homodimerizes , 1998, Oncogene.

[263]  C. Cerni,et al.  YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc , 1998, Oncogene.

[264]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[265]  G. Prendergast,et al.  New Myc-interacting proteins: a second Myc network emerges , 1999, Oncogene.

[266]  W. Shoji,et al.  Direct association of YY-1 with c-Myc and the E-box binding protein in regulation of glycophorin gene expression , 1998, Oncogene.

[267]  J. Moore,et al.  Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[268]  B. Amati,et al.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. , 2000, Nucleic acids research.

[269]  V. Stewart,et al.  Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. , 1992, Genes & development.

[270]  P R Nicholson,et al.  The Saccharomyces cerevisiae SIN3 gene, a negative regulator of HO, contains four paired amphipathic helix motifs , 1990, Molecular and cellular biology.

[271]  Andreas Sewing,et al.  Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes , 1997, Oncogene.

[272]  L. Larsson,et al.  Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. , 1994, Oncogene.

[273]  J. Kennison,et al.  dMi-2, a hunchback-interacting protein that functions in polycomb repression. , 1998, Science.

[274]  R. Roeder,et al.  A Human SPT3-TAFII31-GCN5-L Acetylase Complex Distinct from Transcription Factor IID* , 1998, The Journal of Biological Chemistry.

[275]  A. Bradley,et al.  Mutation of N-myc in mice: what does the phenotype tell us? , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[276]  M. Cole,et al.  c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. , 1998, Genes & development.

[277]  P. Goodfellow,et al.  Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma. , 1996, Cancer letters.

[278]  A. W. Harris,et al.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells , 1988, The Journal of experimental medicine.

[279]  R. DePinho,et al.  Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. , 1994, Seminars in cancer biology.

[280]  H. Wang,et al.  Transcriptional repression in Saccharomyces cerevisiae by a SIN3-LexA fusion protein , 1993, Molecular and cellular biology.

[281]  R. Eisenman,et al.  FH3, a v-myc avian retrovirus with limited transforming ability , 1989, Journal of virology.

[282]  S. G. Cheng,et al.  c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function , 1999, Nature Genetics.

[283]  R. DePinho,et al.  Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells , 1995, Nature Medicine.

[284]  J. Neil,et al.  Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles , 1999, Oncogene.

[285]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[286]  H. Kondoh,et al.  Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. , 1993, Development.

[287]  P. Neiman,et al.  Angiogenesis is an early event in the generation of myc-induced lymphomas , 2000, Oncogene.

[288]  L. Chin,et al.  Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.

[289]  D. Felsher,et al.  Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[290]  S Gaubatz,et al.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.